Thoracic Tumors: Decoding Cellular Heterogeneity, Tumor Microenvironment Crosstalk, and Therapeutic Vulnerabilities
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Microenvironment".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 63
Special Issue Editors
2. Clinic for Pulmonology, University Clinical Center of Serbia, 11000 Belgrade, Serbia
Interests: lung cancer
Special Issue Information
Dear Colleagues,
Lung cancer is the leading cause of cancer-related death among both men and women. New treatment options have led to prolonged time to disease progression and improved overall survival in some groups of patients. Thus, immunotherapy and molecular therapy have become the standard of care for all stages of lung cancer. Immunotherapy can also be used in the treatment of other thoracic tumors, such as mesothelioma and thymic carcinoma. However, for some patient groups, chemotherapy is still an option.
In this Special Issue, we invite researchers to submit original articles and reviews addressing all types of thoracic tumors.
Dr. Vesna Ceriman Krstic
Prof. Dr. Dragana Jovanovic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- NSCLC
- SCLC
- mesothelioma
- thymoma
- thymic carcinoma
- immunotherapy
- molecular therapy
- chemotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
